HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sumihito Nobusawa Selected Research

Oligodendroglioma

1/2020Oligodendroglioma showing pleomorphic xanthoastrocytoma-like perivascular microlesion: With IDH1, TERT promoter mutation and 1p/19q codeletion detected in both components.
10/2013A case of oligodendroglioma with prominent neuronal differentiation.
7/2012Nestin expression in brain tumors: its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomas.
3/2012Pathologic diversity of glioneuronal tumor with neuropil-like islands: a histological and immunohistochemical study with a special reference to isocitrate dehydrogenase 1 (IDH1) in 5 cases.
11/2011Alterations in the RB1 pathway in low-grade diffuse gliomas lacking common genetic alterations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sumihito Nobusawa Research Topics

Disease

36Neoplasms (Cancer)
05/2022 - 05/2004
17Glioma (Gliomas)
10/2019 - 04/2009
14Glioblastoma (Glioblastoma Multiforme)
03/2020 - 02/2009
6Neuroepithelial Neoplasms (Gliomatosis Cerebri)
10/2021 - 12/2018
6Brain Neoplasms (Brain Tumor)
01/2020 - 05/2004
5Oligodendroglioma
01/2020 - 11/2011
4Ependymoma
01/2021 - 10/2014
4Astrocytoma (Pilocytic Astrocytoma)
08/2017 - 11/2011
3Rhabdoid Tumor (Rhabdoid Tumors)
01/2021 - 02/2016
2Hepatocellular Carcinoma (Hepatoma)
02/2021 - 05/2020
2Primitive Neuroectodermal Tumors (PNET)
10/2019 - 03/2012
2Necrosis
01/2018 - 08/2017
2Meningioma (Meningiomas)
10/2013 - 01/2012
1Prostatic Neoplasms (Prostate Cancer)
12/2021
1Ewing Sarcoma (Sarcoma, Ewing)
10/2021
1Biliary Fistula
02/2021
1Liver Neoplasms (Liver Cancer)
01/2021
1Carcinoma (Carcinomatosis)
01/2021
1Carcinogenesis
01/2021
1Acidophil Adenoma
01/2021
1Adenoma (Adenomas)
05/2020
1Focal Nodular Hyperplasia
05/2020
1Liver Cell Adenoma (Hepatocellular Adenoma)
05/2020
1Pinealoma (Pineoblastoma)
01/2020
1Adenocarcinoma
09/2019
1Pituitary Neoplasms (Pituitary Adenoma)
01/2018
1alpha-Thalassemia
10/2017
1Intellectual Disability (Idiocy)
10/2017
1Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy)
08/2017
1Ganglioglioma
08/2017
1Liver Failure
01/2017
1Jaundice (Icterus)
01/2017
1Hepatic Encephalopathy
01/2017
1Multiple Sclerosis
01/2017
1Teratoma (Teratoid Tumor)
03/2016

Drug/Important Bio-Agent (IBA)

10Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
03/2020 - 04/2009
8Proteins (Proteins, Gene)FDA Link
05/2020 - 05/2004
5DNA (Deoxyribonucleic Acid)IBA
10/2017 - 02/2009
4Biomarkers (Surrogate Marker)IBA
10/2017 - 01/2012
3MicroRNAs (MicroRNA)IBA
05/2022 - 03/2012
3Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
07/2021 - 05/2019
3Cyclin-Dependent Kinase Inhibitor p16IBA
03/2020 - 09/2010
3Biological ProductsIBA
10/2019 - 04/2009
3Oligodendrocyte Transcription Factor 2IBA
12/2018 - 06/2013
3SynaptophysinIBA
03/2018 - 10/2012
3alpha-internexinIBA
12/2015 - 10/2014
2GadoliniumIBA
10/2021 - 07/2020
2Temozolomide (Temodar)FDA LinkGeneric
09/2020 - 01/2018
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2020 - 10/2014
2Glial Fibrillary Acidic ProteinIBA
03/2020 - 12/2018
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2020 - 10/2017
2Mucin-1 (CA 15-3 Antigen)IBA
12/2018 - 06/2013
2Histones (Histone)IBA
10/2017 - 07/2017
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
04/2016 - 07/2014
2NestinIBA
03/2016 - 07/2012
2Genetic Markers (Genetic Marker)IBA
06/2013 - 10/2009
2Tumor Suppressor Protein p14ARF (p14ARF)IBA
11/2011 - 09/2010
1AndrogensIBA
12/2021
1LigandsIBA
12/2021
1Androgen Receptors (Androgen Receptor)IBA
12/2021
1RNA-Binding Protein EWSIBA
10/2021
1Co-Repressor ProteinsIBA
05/2021
1Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2021
1PregnenoloneIBA
01/2021
1CAM 5.2 antigenIBA
01/2021
1IntegrasesIBA
01/2021
1Pregnane X ReceptorIBA
01/2021
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2021
1Phenobarbital (Luminal)FDA Link
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Pregnenolone Carbonitrile (PCN)IBA
01/2021
1Tumor Biomarkers (Tumor Markers)IBA
05/2020
1acarboxyprothrombin (PIVKA)IBA
05/2020
1Vitamin KFDA Link
05/2020
12,6-dinitrotoluene (DNT)IBA
04/2020
1VimentinIBA
03/2020
1Keratins (Keratin)IBA
03/2020
1ElementsIBA
01/2020
1Oxidoreductases (Dehydrogenase)IBA
10/2018
1Bevacizumab (Avastin)FDA Link
01/2018
1S100 Proteins (S 100 Protein)IBA
01/2018
1ChromatinIBA
01/2018
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
01/2018
1Reticulin (Reticular Fiber)IBA
08/2017
1polyglutamineIBA
08/2017
1InterferonsIBA
01/2017

Therapy/Procedure

7Therapeutics
01/2021 - 01/2016
3Radiotherapy
09/2020 - 01/2018
3Ligation
04/2020 - 01/2018
2Drug Therapy (Chemotherapy)
05/2022 - 09/2020
1Combined Modality Therapy
05/2022
1Laminectomy
10/2021
1Aftercare (After-Treatment)
02/2021
1Hepatectomy
05/2020
1Craniotomy
01/2020
1Lymph Node Excision (Lymph Node Dissection)
09/2019
1Adjuvant Chemoradiotherapy
08/2017
1Hemodiafiltration
01/2017
1Plasma Exchange
01/2017
1Critical Care (Surgical Intensive Care)
01/2017